• Latest

AstraZeneca to use Russian COVID-19 vaccine in trials

December 11, 2020

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Childhood diet and exercise creates healthier, less anxious adults

April 9, 2021

Metabolic changes in fat tissue in obesity associated with adverse health effects

April 9, 2021

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Brazil at high risk of dengue outbreaks after droughts because of temporary water storage

April 9, 2021

14 states report 83 new COVID-19 cases

April 9, 2021

Less than 2% of global COVID-19 vaccines administered in Africa

April 9, 2021

Customers risk infection as Kano suya spot employees test positive for Hepatitis B

April 9, 2021

More countries halt AstraZeneca vaccine use among younger people

April 9, 2021

Health benefits of breastfeeding, for mother: Lactation and visceral, pericardial fat

April 9, 2021

Childhood diet and exercise creates healthier, less anxious adults

April 9, 2021

Toward a reliable oral treatment for sickle cell disease

April 9, 2021
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Saturday, April 10, 2021
  • Login
Well Beign
Advertisement
  • Home
  • News
  • Fitness
  • food
  • Diets
  • Lifestyle
No Result
View All Result
  • Home
  • News
  • Fitness
  • food
  • Diets
  • Lifestyle
No Result
View All Result
Well Beign
No Result
View All Result
Home News

AstraZeneca to use Russian COVID-19 vaccine in trials

by
December 11, 2020
in News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Pharmaceutical giant AstraZeneca’s Russian branch said on Friday that it would use part of Russia’s homemade Sputnik V vaccine in further clinical trials, a major sign of recognition for a jab that has been viewed with scepticism by the West. 

Russia was one of the first countries to announce the development of a coronavirus vaccine, which it named Sputnik V after the Soviet-era satellite.

While the jab is yet to complete its third and final phase of testing involving some 40,000 volunteers, its developers have said that interim trial results showed 95 per cent efficacy. 

“Today we announce a clinical trial programme to assess the safety and immunogenicity of a combination of AZD1222, developed by AstraZeneca and Oxford University, and Sputnik V, developed by Russian Gamaleya Research institute,” AstraZeneca said in a statement published on its website in English and Russian on Friday.

The pharmaceutical company said that adults aged 18 and over will be enrolled in the trials, expected to start before the end of the year.

While the Sputnik V jab uses human adenovirus vectors, AZD1222 relies on adenovirus from chimpanzees. Both are administered in two doses.

Russia’s Direct Investment Fund, which was involved in the development of Sputnik V, said in its statement on Friday that on November 23 it offered AstraZeneca “to use one of the two vectors of the Sputnik V vaccine in additional clinical trials of its vaccine”.

Moscow announced the registration of Sputnik V back in August after it had completed the second phase of trials on under 100 volunteers, raising concerns from scientists at home and abroad. 

Analysts viewed the fast-track registration and the early launch of mass vaccination as an effort for Russia to bolster its geopolitical influence. 

Several Russian allies – including India, Venezuela and Belarus – have said they would take part in clinical trials for the jab, while Kremlin-friendly governments have pre-ordered more than a billion doses of Sputnik V.

Ignoring accusations by Britain of Russian-linked hackers targeting vaccine research, Moscow has said it is open to cooperation with Western countries.

The vaccine’s developers said it will be available on international markets for less than $10 (8.40 euros) per dose — and that it can be stored at between two and eight degrees Celsius (between 35.6 and 46.4 degrees Fahrenheit) instead of the temperatures far below freezing required for some other vaccines.

In its statement on Friday, AstraZeneca said that “combinations of different COVID-19 vaccines may be an important step in generating wider protection through a stronger immune response and better accessibility.”

The British-Swedish drugmaker added that cooperation with the Gamaleya Research Institute is “important to explore the potential of vaccine combinations unlocking synergies in protection and accessibility through a portfolio approach.”

The pharmaceutical giant had earlier said that its vaccine was on average 70 per cent effective.

Head of RDIF Kirill Dmitriyev said on Friday that the collaboration will be a “unique example of cooperation between scientists from different countries in jointly fighting coronavirus”. 

While Russia’s second wave has continued to surge in recent weeks, the country has refrained from reimposing a strict nationwide lockdown as it did in the spring and pinned its hopes on mass vaccination. 

Last week Russia started a large-scale public vaccination drive, offering Sputnik V initially to people in high-risk groups including medical workers and teachers. 

On Friday it reported 613 virus deaths over the past 24 hours, surpassing the 600 marks for the first time since the beginning of the pandemic.

Total fatalities stood at 45,893, while infections jumped to 2,597,711, placing Russia’s caseload fourth-highest in the world. 

Russia has reported a much lower death rate than other badly hit countries, raising concerns that authorities have downplayed the outbreak.

Data published by the country’s federal statistics service on Thursday indicated excess deaths of nearly 165,000 year-on-year between March and October, suggesting virus deaths could be much higher.

(AFP)

The post AstraZeneca to use Russian COVID-19 vaccine in trials appeared first on Healthwise.

Previous Post

Sanofi, GSK COVID-19 vaccine delayed until end of 2021 

Next Post

Test your heart health by climbing stairs

Next Post

Test your heart health by climbing stairs

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected test

  • 85 Followers
  • 23k Followers
  • 99 Subscribers
  • Trending
  • Comments
  • Latest

Death by prescription: How doctors’ sloppy handwriting causes avoidable drug dispensing errors

January 17, 2021

We didn’t hear from Lagos govt again -Family of 23-year-old #ENDSARS shooting amputee

December 7, 2020

Foreign arrivals presenting fake COVID-19 test results, FG cries out

November 24, 2020

Too much sex is bad for you

December 29, 2020

Hello world!

0

“Who still thinks about Corona Virus?”

0

Health is the essential underpinning of productive, resilient and stable economies – WHO DG

0

Zebra finches amazing at unmasking the bird behind the song

0

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Childhood diet and exercise creates healthier, less anxious adults

April 9, 2021

Metabolic changes in fat tissue in obesity associated with adverse health effects

April 9, 2021

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Recent News

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Childhood diet and exercise creates healthier, less anxious adults

April 9, 2021

Metabolic changes in fat tissue in obesity associated with adverse health effects

April 9, 2021

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

We bring you the best Health and Nutrition News and Tips to help you stay healthy. Subscribe to our newsletter to get new posts when the appear on our blog.

Follow Us

Browse by Category

  • Apps
  • Business
  • Diets
  • Entertainment
  • Fashion
  • Fitness
  • food
  • Gadget
  • Gaming
  • Health
  • Lifestyle
  • Mobile
  • Movie
  • Music
  • News
  • Politics
  • Review
  • Science
  • Sports
  • Startup
  • Tech
  • Travel
  • World

Recent News

Leisure physical activity is linked with health benefits but work activity is not

April 9, 2021

Childhood diet and exercise creates healthier, less anxious adults

April 9, 2021
  • Home
  • News
  • Fitness
  • food
  • Diets
  • Lifestyle

© 2021 WellBeign - Proudly designed by WebDesignPro WebDesignPro.

No Result
View All Result
  • Home
  • News
  • Fitness
  • food
  • Diets
  • Lifestyle

© 2021 WellBeign - Proudly designed by WebDesignPro WebDesignPro.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In